Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials

Pharmacoepidemiology and Drug Safety
Giovanni CorraoOlivia Leoni

Abstract

Although it is well known that a variety of antibacterials may incidentally cause malignant arrhythmia, the list of drugs causing arrhythmia and the impact of these adverse effects are still uncertain. We investigated on this topic by using a large prescription database with different observational designs. Prescription data on all incident users of several antibacterial and antiarrhythmic drugs over the period July 1997 through December 1999 were retrieved from the Drug Prescription Database (DPD) of the Italian Province of Varese. The association between the use of antibacterial and antiarrhythmic drugs was investigated by applying prescription sequence symmetry, cohort and nested case-control designs. Lower proarrhythmic effects were on an average obtained from prescription sequence symmetry approach with respect to both cohort and nested case-control. Evidence of association between exposure to drugs (erythromycin and ciprofloxacin) and the risk of arrhythmia was consistently found by the three approaches. No other signals were generated from the prescription sequence symmetry analysis. Two drugs (clarithromycin and levofloxacin) showed patterns compatible with an arrhythmic effect according to both cohort and nested case-c...Continue Reading

References

Apr 1, 1991·Statistics in Medicine·H Petri, J Urquhart
Jan 1, 1990·Journal of Clinical Epidemiology·H PetriJ Urquhart
May 3, 2000·British Journal of Clinical Pharmacology·I A ElandL A Rodríguez
Nov 9, 2000·Alimentary Pharmacology & Therapeutics·P Bytzer, J Hallas
Feb 13, 2001·BMJ : British Medical Journal·J A Sterne, G Davey Smith
May 8, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabrizio De PontiNicola Montanaro
May 16, 2002·Pharmacotherapy·Robert C Owens, Paul G Ambrose
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·J M Evans, T M MacDonald
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·G Lindberg, J Hallas
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·A D McMahonT M MacDonald

❮ Previous
Next ❯

Citations

Oct 1, 2011·Expert Opinion on Drug Safety·Alessandra PugiFrancesco Lapi
Jan 23, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Izyan A WahabElizabeth E Roughead
Mar 28, 2009·Pharmacoepidemiology and Drug Safety·Ioannis TsiropoulosJesper Hallas
Feb 16, 2013·Pharmacoepidemiology and Drug Safety·Izyan A WahabElizabeth E Roughead
May 24, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yoshinori TakeuchiYoshiaki Uyama
Mar 22, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Muaed Jamal Alomar
Mar 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Van BambekeP M Tulkens
Dec 14, 2016·Journal of Clinical Pharmacy and Therapeutics·P S Nishtala, T-Y Chyou
Jun 4, 2019·Expert Review of Clinical Pharmacology·Catia Marzolini, Françoise Livio
Apr 1, 2008·Ciência & saúde coletiva·Paola NicoliniFabianna Gatti de Menezes
Oct 20, 2017·European Journal of Clinical Pharmacology·A BiffiUNKNOWN Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)
Jan 1, 2019·Current Epidemiology Reports·Nicole Pratt, Elizabeth Roughead
Apr 12, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Angel Y S WongIan C K Wong
Jul 13, 2017·European Journal of Epidemiology·Edward Chia-Cheng LaiJesper Hallas
Jun 3, 2021·Toxins·Kiersten D LenzJessica Z Kubicek-Sutherland
Aug 12, 2021·Research in Social & Administrative Pharmacy : RSAP·Earl J MorrisScott M Vouri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.